SF6 是一种长期治疗肺切除术后综合征的有效扩张器:病例报告。

IF 0.7 Q4 SURGERY
Koki Maeda, Nobuhiro Imamura, Keisuke Tabata, Shoichiro Morizono, Takuya Tokunaga, Aya Takeda, Go Kamimura, Oniwa Masashi, Keiko Mizuno, Masaya Aoki, Kazuhiro Ueda
{"title":"SF6 是一种长期治疗肺切除术后综合征的有效扩张器:病例报告。","authors":"Koki Maeda, Nobuhiro Imamura, Keisuke Tabata, Shoichiro Morizono, Takuya Tokunaga, Aya Takeda, Go Kamimura, Oniwa Masashi, Keiko Mizuno, Masaya Aoki, Kazuhiro Ueda","doi":"10.1186/s40792-024-01972-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Post-pneumonectomy syndrome (PPS) is a rare but serious condition that can occur after pneumonectomy. It is characterized by a mediastinal shift towards the vacated hemithorax, which can potentially lead to respiratory failure. The management of PPS poses a clinical challenge, especially in the context of the limited availability of certain therapeutic devices due to regulatory restrictions in Japan.</p><p><strong>Case presentation: </strong>A 36-year-old female with stage IB non-small cell lung cancer underwent left pneumonectomy. Approximately 2 years later, she developed dyspnea. After consulting with our hospital, subsequent imaging revealed an extreme mediastinal shift causing bronchial obstruction. Emergency thoracotomy and subsequent sulfur hexafluoride (SF<sub>6</sub>) injections were successfully used to manage her condition. Over the course of follow-up, the interval between SF<sub>6</sub> injections was extended from 3 to 11 months, indicating an improvement in the intrathoracic condition.</p><p><strong>Conclusions: </strong>This case illustrates the efficacy of SF<sub>6</sub> gas in treating PPS and in reducing the frequency of medical interventions. SF<sub>6</sub> gas administration is safe and effective for the treatment of patients with PPS.</p>","PeriodicalId":22096,"journal":{"name":"Surgical Case Reports","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254868/pdf/","citationCount":"0","resultStr":"{\"title\":\"SF<sub>6</sub> is a useful expander for post-pneumonectomy syndrome in the long-term course: a case report.\",\"authors\":\"Koki Maeda, Nobuhiro Imamura, Keisuke Tabata, Shoichiro Morizono, Takuya Tokunaga, Aya Takeda, Go Kamimura, Oniwa Masashi, Keiko Mizuno, Masaya Aoki, Kazuhiro Ueda\",\"doi\":\"10.1186/s40792-024-01972-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Post-pneumonectomy syndrome (PPS) is a rare but serious condition that can occur after pneumonectomy. It is characterized by a mediastinal shift towards the vacated hemithorax, which can potentially lead to respiratory failure. The management of PPS poses a clinical challenge, especially in the context of the limited availability of certain therapeutic devices due to regulatory restrictions in Japan.</p><p><strong>Case presentation: </strong>A 36-year-old female with stage IB non-small cell lung cancer underwent left pneumonectomy. Approximately 2 years later, she developed dyspnea. After consulting with our hospital, subsequent imaging revealed an extreme mediastinal shift causing bronchial obstruction. Emergency thoracotomy and subsequent sulfur hexafluoride (SF<sub>6</sub>) injections were successfully used to manage her condition. Over the course of follow-up, the interval between SF<sub>6</sub> injections was extended from 3 to 11 months, indicating an improvement in the intrathoracic condition.</p><p><strong>Conclusions: </strong>This case illustrates the efficacy of SF<sub>6</sub> gas in treating PPS and in reducing the frequency of medical interventions. SF<sub>6</sub> gas administration is safe and effective for the treatment of patients with PPS.</p>\",\"PeriodicalId\":22096,\"journal\":{\"name\":\"Surgical Case Reports\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2024-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254868/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgical Case Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s40792-024-01972-0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40792-024-01972-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

背景:肺切除术后综合征(PPS)是肺切除术后可能出现的一种罕见但严重的病症。其特点是纵隔向空出的半胸腔移位,有可能导致呼吸衰竭。PPS 的治疗是一项临床挑战,尤其是在日本,由于监管限制,某些治疗设备的供应有限:一名 36 岁女性,患有 IB 期非小细胞肺癌,接受了左肺切除术。大约两年后,她出现了呼吸困难。经本院会诊,随后的影像学检查发现纵隔极度移位导致支气管阻塞。紧急开胸手术和随后的六氟化硫(SF6)注射成功地控制了她的病情。在随访过程中,SF6 注射的间隔时间从 3 个月延长至 11 个月,表明胸腔内的情况有所改善:本病例说明了 SF6 气体在治疗 PPS 和减少医疗干预频率方面的疗效。使用 SF6 气体治疗 PPS 患者安全有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
SF6 is a useful expander for post-pneumonectomy syndrome in the long-term course: a case report.

Background: Post-pneumonectomy syndrome (PPS) is a rare but serious condition that can occur after pneumonectomy. It is characterized by a mediastinal shift towards the vacated hemithorax, which can potentially lead to respiratory failure. The management of PPS poses a clinical challenge, especially in the context of the limited availability of certain therapeutic devices due to regulatory restrictions in Japan.

Case presentation: A 36-year-old female with stage IB non-small cell lung cancer underwent left pneumonectomy. Approximately 2 years later, she developed dyspnea. After consulting with our hospital, subsequent imaging revealed an extreme mediastinal shift causing bronchial obstruction. Emergency thoracotomy and subsequent sulfur hexafluoride (SF6) injections were successfully used to manage her condition. Over the course of follow-up, the interval between SF6 injections was extended from 3 to 11 months, indicating an improvement in the intrathoracic condition.

Conclusions: This case illustrates the efficacy of SF6 gas in treating PPS and in reducing the frequency of medical interventions. SF6 gas administration is safe and effective for the treatment of patients with PPS.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
218
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信